Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes.

Predieri, Barbara; Suprani, Tosca; Maltoni, Giulio; Graziani, Vanna; Bruzzi, Patrizia; Zucchini, Stefano; Iughetti, Lorenzo

Predieri, Barbara; Suprani, Tosca; Maltoni, Giulio; Graziani, Vanna; Bruzzi, Patrizia; Zucchini, Stefano; Iughetti, Lorenzo.

Afiliación

Predieri B; Department of Medical and Surgical Sciences of the Mother, Children and Adults, Pediatric Unit, University of Modena and Reggio Emilia, Modena, Italy.
Suprani T; Department of Pediatrics, Bufalini Hospital, Cesena, Italy.
Maltoni G; Department of Pediatrics, S. Orsola-Malpighi Hospital, Bologna, Italy.
Graziani V; Department of Pediatrics, Santa Maria Delle Croci Hospital, Ravenna, Italy.
Bruzzi P; Department of Medical and Surgical Sciences of the Mother, Children and Adults, Pediatric Unit, University of Modena and Reggio Emilia, Modena, Italy.
Zucchini S; Department of Pediatrics, S. Orsola-Malpighi Hospital, Bologna, Italy.
Iughetti L; Department of Medical and Surgical Sciences of the Mother, Children and Adults, Pediatric Unit, University of Modena and Reggio Emilia, Modena, Italy.

Front Endocrinol (Lausanne) ; 9: 462, 2018.

Article en En | MEDLINE | ID: mdl-30190702

Palabras clave

basal-bolus therapy; children; glycemic control; insulin degludec; safety; type 1 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2018 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google